1st Quarter - Report

AMGEN, INC. for AMGEN INC

Firm
Client
Income
—
Expenses
$2,520,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Intellectual property and process patent issues S. 1145 and H.R.. 1908 Patent Reform Act of 2007

LobbyistCovered position, as disclosed
DAVID BEIER —
CHAKA BURGESS —
L NICOLE CURRIE —
RODGER CURRIE —
MARA GUARDUCCI —
JESSE KERNS —
REBECCA MANDELL —
HOWARD MOON —
WILLIAM O'BRIEN —
SCOTT OLSEN —
HELEN RHEE —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Commerce, Dept of (DOC)

Bills named: S. 1145 (110th)

Health Issues HCR

FDA Drug Safety Oversight Follow-On-Biologics H.R. 1038, Access to Life-saving Medicines Act H.R. 1956, Patient Protection and Innovative Biologics Medicines Act of 2007 HR. 5629, Pathway for Biosimilars Act

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1038 (110th), H.R. 5629 (110th), H.R. 1956 (110th)

Medicare/Medicaid MMM

Medicare Coverage and Reimbursement Issues Implementation of the Medicaid Drug Rebate Program

Contacted: Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Executive Office of the President (EOP); SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.